225 related articles for article (PubMed ID: 10633052)
21. Inconsistencies in endoscope-reprocessing and infection-control guidelines: the importance of endoscope drying.
Muscarella LF
Am J Gastroenterol; 2006 Sep; 101(9):2147-54. PubMed ID: 16968511
[TBL] [Abstract][Full Text] [Related]
22. Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations.
Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Aghdam MK; Lotfollahzadeh S; Hosseini A; Dara N; Nanbakhsh M; Gorji FA
BMC Pulm Med; 2020 Feb; 20(1):33. PubMed ID: 32028925
[TBL] [Abstract][Full Text] [Related]
23. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
[TBL] [Abstract][Full Text] [Related]
24. Energetic cost of physical activity in cystic fibrosis children during Pseudomonas aeruginosa pulmonary exacerbation.
Béghin L; Gottrand F; Michaud L; Vodougnon H; Wizla-Derambure N; Hankard R; Husson MO; Turck D
Clin Nutr; 2005 Feb; 24(1):88-96. PubMed ID: 15681106
[TBL] [Abstract][Full Text] [Related]
25. [Studies of microbiological contamination of ultrasonic apparatus used in pediatric aerosol therapy].
Alkiewicz J; Kedzia B; Hołderna E; Bugaj U
Pol Tyg Lek; 1989 Aug 21-28; 44(34-35):813-6. PubMed ID: 2485899
[TBL] [Abstract][Full Text] [Related]
26. Microbial contamination of mist therapy units on six pediatric wards.
Petersen NJ; Carson LA; Favero MS; Marshall JH; Bond WW
Health Lab Sci; 1975 Jan; 12(1):41-6. PubMed ID: 1052502
[TBL] [Abstract][Full Text] [Related]
27. Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough?
Rosenfeld M; Joy P; Nguyen CD; Krzewinski J; Burns JL
J Hosp Infect; 2001 Nov; 49(3):229-30. PubMed ID: 11716644
[No Abstract] [Full Text] [Related]
28. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
Fitzgerald DA; Hilton J; Jepson B; Smith L
Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
[TBL] [Abstract][Full Text] [Related]
29. Cleaning and infection control of airway clearance devices used by CF patients.
Manor E; Gur M; Geffen Y; Bentur L
Chron Respir Dis; 2017 Nov; 14(4):370-376. PubMed ID: 28513198
[TBL] [Abstract][Full Text] [Related]
30. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
31. Bacterial contamination of cystic fibrosis clinics.
Zuckerman JB; Zuaro DE; Prato BS; Ruoff KL; Sawicki RW; Quinton HB; Saiman L;
J Cyst Fibros; 2009 May; 8(3):186-92. PubMed ID: 19250885
[TBL] [Abstract][Full Text] [Related]
32. [Microorganisms in home-care inhalation devices].
Exner M; Vogel F; Rost HD
Dtsch Med Wochenschr; 1983 Jan; 108(1):12-7. PubMed ID: 6848339
[TBL] [Abstract][Full Text] [Related]
33. Device Cleaning and Infection Control in Aerosol Therapy.
O'Malley CA
Respir Care; 2015 Jun; 60(6):917-27; discussion 928-30. PubMed ID: 26070583
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
35. Late effect of nocturnal mist tent therapy related to the severity of airway obstruction in children with cystic fibrosis.
Bureau MA; McDougall DM; Beaudry PH; Belmonte MM
Pediatrics; 1978 Jun; 61(6):842-6. PubMed ID: 673547
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve.
Motoyama EK; Gibson LE; Zigas CJ
Pediatrics; 1972 Aug; 50(2):299-306. PubMed ID: 5045357
[No Abstract] [Full Text] [Related]
37. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
[TBL] [Abstract][Full Text] [Related]
38. Whirlpool baths in nursing homes: use, maintenance, and contamination with Pseudomonas aeruginosa.
Hollyoak V; Boyd P; Freeman R
Commun Dis Rep CDR Rev; 1995 Jun; 5(7):R102-4. PubMed ID: 7613584
[TBL] [Abstract][Full Text] [Related]
39. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
40. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
